Talphera, Inc. is a specialized pharmaceutical company dedicated to advancing and commercializing innovative therapies tailored for use in medically supervised environments. The company's flagship product, Niyad™, is a lyophilized formulation of nafamostat, currently undergoing investigation under an investigational device exemption (IDE). Niyad™ is specifically being studied as an anticoagulant for the extracorporeal circ...
Talphera, Inc. is a specialized pharmaceutical company dedicated to advancing and commercializing innovative therapies tailored for use in medically supervised environments. The company's flagship product, Niyad™, is a lyophilized formulation of nafamostat, currently undergoing investigation under an investigational device exemption (IDE). Niyad™ is specifically being studied as an anticoagulant for the extracorporeal circuit and has received Breakthrough Device Designation status from the FDA. In addition, Talphera is actively involved in the development of two pre-filled syringes, Fedsyra™ and PFS-02.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.